
Proteomics Market Report 2026
Global Outlook – By Component (Reagents, Instruments, Software), By Instrument (Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation ), By Type (Core Instrument Services, Proteomic Analytical Services) - Market Size, Trends, And Global Forecast 2026-2035
Proteomics Market Overview
• Proteomics market size has reached to $39.37 billion in 2025 • Expected to grow to $73.33 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Proteomics Market Growth Driven By The Expanding Pharmaceutical Industry • Market Trend: Increasing Focus On Developing Precise Quantitative Analysis Kit To Gain A Competitive Edge • North America was the largest region in 2025 and Western Europe is the fastest growing region.What Is Covered Under Proteomics Market?
Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. Proteomics is used to evaluate the protein production rate, the involvement of proteins in metabolic pathways, and the modifications of proteins. The main types of proteomics are protein microarrays, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance, and protein fractionation. The various components used are reagents, instruments, and software that are used for proteomic analytical services and instrument services.
What Is The Proteomics Market Size and Share 2026?
The proteomics market size has grown rapidly in recent years. It will grow from $39.37 billion in 2025 to $44.65 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to expansion of life sciences research funding, increasing use of proteomics in drug discovery, availability of high-performance analytical instruments, growth of academic research programs, rising demand for biomarker discovery.What Is The Proteomics Market Growth Forecast?
The proteomics market size is expected to see rapid growth in the next few years. It will grow to $73.33 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in precision medicine initiatives, growing demand for multi-omics analysis, expansion of clinical proteomics applications, rising adoption of AI-driven data analysis tools, increasing focus on disease pathway analysis. Major trends in the forecast period include increasing adoption of advanced proteomic analysis techniques, rising use of mass spectrometry-based proteomics, growing integration of proteomics with genomics data, expansion of cloud-based proteomics platforms, enhanced focus on quantitative proteomics.Global Proteomics Market Segmentation
1) By Component: Reagents, Instruments, Software 2) By Instrument: Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation 3) By Type: Core Instrument Services, Proteomic Analytical Services Subsegments: 1) By Reagents: Protein Assays, Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Electrophoresis Reagents 2) By Instruments: Mass Spectrometry, Chromatography Equipment, Electrophoresis Equipment, Microarray Instruments, X-ray Crystallography Instruments 3) By Software: Data Analysis Software, Bioinformatics Tools, Cloud-Based Platforms For ProteomicsWhat Is The Driver Of The Proteomics Market?
The growing pharmaceutical industry is expected to propel the growth of the proteomics market going forward. The pharmaceutical industry is a sector focused on researching, developing, manufacturing, and distributing drugs and medications for medical use. The pharmaceutical industry is rising because the growing global burden of chronic diseases is increasing the need for continuous drug development and advanced therapeutic solutions, driving sustained market expansion. Proteomics plays a crucial role in drug development by identifying, characterizing, and monitoring proteins for drug targets and biomarker discovery. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the growing pharmaceutical industry is driving the growth of the proteomics industry.Key Players In The Global Proteomics Market
Major companies operating in the proteomics market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Vproteomics, Shimadzu Corporation, Abcam plc, MRM Proteomics Inc., Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc.Global Proteomics Market Trends and Insights
Major companies operating in the proteomics market are focused on developing precise quantitative analysis kits to gain a competitive edge in the market. Precise quantitative analyses kits are kit used for accurately measuring protein expression levels and identifying biomarkers in various biological samples. For instance, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, introduced the Fast Glycan Labeling and Analysis kit, designed for precise quantitative glycan analysis and an update for the Biologics Explorer software, which aims to enhance key workflows for the analysis of protein therapeutics. These solutions are designed to accelerate the examination and recognition of glycans associated with proteins. They furnish researchers with advanced resources for in-depth biopharmaceutical analysis. The software empowers researchers to make informed decisions regarding the most suitable analytical methods and tools for their specific applications. This, in turn, enhances the efficiency and effectiveness of protein characterization studies.What Are Latest Mergers And Acquisitions In The Proteomics Market?
In July 2024, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired Olink Holding, for approximately $3.1 billion. This acquisition aligns with Thermo Fisher's strategy to enhance its portfolio of innovative technologies. The company aims to leverage Olink's proprietary Proximity Extension Assay (PEA) technology, which enables high-throughput protein analysis for quantitative polymerase chain reaction and next-generation sequencing readout systems. PEA boasts a library of over 5,300 validated protein biomarker targets, enhancing Thermo Fisher's capabilities in proteomics research. Olink Holding, a Sweden-based provider of next-generation proteomics solutions.Regional Outlook
North America was the largest region in the proteomics market in 2025. Western Europe was the second largest region in the global proteomics market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Proteomics Market?
The proteomics market consists of sales of proteins that are used for drug discovery, clinical diagnosis, molecular medicine and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Proteomics Market Report 2026?
The proteomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the proteomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Proteomics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $44.65 billion |
| Revenue Forecast In 2035 | $73.33 billion |
| Growth Rate | CAGR of 13.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Instrument, Type |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Vproteomics, Shimadzu Corporation, Abcam plc, MRM Proteomics Inc., Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
